RT Journal Article
SR Electronic
T1 Counter-intuitive COVID-19 Trajectories – Explanations, Early Warning Indicator and Mitigation Strategies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.27.21264174
DO 10.1101/2021.09.27.21264174
A1 Shayak, B
A1 Sharma, Mohit M
YR 2021
UL http://medrxiv.org/content/early/2021/09/29/2021.09.27.21264174.abstract
AB The COVID-19 trajectories worldwide have shown several surprising features which are outside the purview of classical epidemiological models. These include (a) almost constant and low daily case rates over extended periods of time, (b) sudden waves emerging from the above solution despite no or minimal change in the level of non-pharmaceutical interventions (NPI), and (c) reduction or flattening of case counts following relaxation of NPI. To explain these phenomena, we add contact tracing to our recently developed cluster seeding and transmission (CST) model. We find no fewer than four effects which make prediction of epidemic trajectories uncertain. These are (a) cryptogenic instability, where a small increase in population-averaged contact rate causes a large increase in cases, (b) critical mass effect, where a wave manifests after weeks of quiescence with no change in parameter values, (c) knife-edge effect, where a small change in parameter across a critical value causes a huge change in the response of the system, and (d) hysteresis effect, where the timing and not just the strength of a particular NPI determines the subsequent behaviour. Despite these effects however, some non-obvious conclusions regarding NPI appear to be robust. In particular, (a) narrowing the circle of one’s social interactions can be as effective a measure as reducing interactions altogether, and (b) a good contact tracing program can effectively substitute for much more invasive measures. Finally, we propose the contact tracing capacity ratio – a metric of the load to which the tracers are subject – as a reliable early warning indicator of an imminent epidemic wave.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe have NOT received any funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval needed for mathematical modeling studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis Article does not use data. All simulation code is available on demand.